SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 238 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $590,000 | +34.7% | 13,000 | 0.0% | 0.72% | +41.5% |
Q2 2017 | $438,000 | +13.8% | 13,000 | 0.0% | 0.51% | +20.9% |
Q1 2017 | $385,000 | +7.8% | 13,000 | 0.0% | 0.42% | +10.5% |
Q4 2016 | $357,000 | -55.0% | 13,000 | 0.0% | 0.38% | -49.3% |
Q3 2016 | $793,000 | +219.8% | 13,000 | 0.0% | 0.75% | +223.7% |
Q2 2016 | $248,000 | -2.4% | 13,000 | 0.0% | 0.23% | 0.0% |
Q1 2016 | $254,000 | -54.4% | 13,000 | -9.9% | 0.23% | -46.8% |
Q4 2015 | $557,000 | +20.3% | 14,425 | 0.0% | 0.44% | +17.5% |
Q3 2015 | $463,000 | +5.5% | 14,425 | 0.0% | 0.37% | +24.1% |
Q2 2015 | $439,000 | +128.6% | 14,425 | 0.0% | 0.30% | +109.1% |
Q1 2015 | $192,000 | -13.9% | 14,425 | -6.5% | 0.14% | +19.2% |
Q4 2014 | $223,000 | +10.9% | 15,425 | +61.9% | 0.12% | +11.1% |
Q3 2014 | $201,000 | -2.9% | 9,525 | +10.4% | 0.11% | -1.8% |
Q1 2014 | $207,000 | -3.3% | 8,625 | -18.1% | 0.11% | -5.2% |
Q4 2013 | $214,000 | -30.7% | 10,525 | +60.9% | 0.12% | -33.7% |
Q3 2013 | $309,000 | +35.5% | 6,540 | +9.0% | 0.18% | +35.7% |
Q2 2013 | $228,000 | – | 6,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |